Raymond James Financial Services Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-10,600
Closed -$3K 3417
2021
Q4
$3K Sell
10,600
-21,800
-67% -$1.74M ﹤0.01% 3288
2021
Q3
$112K Buy
32,400
+1,800
+6% +$137K ﹤0.01% 3106
2021
Q2
$95K Buy
+30,600
New +$2.28M ﹤0.01% 3145

Other funds holding MRK

Raymond James Financial Services Advisors's MRK Position: Q3 2024 in Review

Raymond James Financial Services Advisors reduced its Merck (MRK) stake by 0.85% in Q3 2024, selling an estimated $3.67M and leaving 3,603,148 shares worth $409M. The position accounts for 0.55% of the portfolio, ranked #33.

Raymond James Financial Services Advisors first reported a position in MRK in Q2 2013 and has held it in 45 quarters since. The position peaked at $472M in Q1 2024. 3,490 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

  • Raymond James Financial Services Advisors held 3,603,148 shares of Merck worth $409M as of Q3 2024.
  • Raymond James Financial Services Advisors sold 30,866 Merck shares in Q3 2024, an estimated $3.67M.
  • Merck made up 0.55% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #33 holding.
  • Raymond James Financial Services Advisors first reported a position in Merck in Q2 2013 and has held it in 45 quarters since.
  • Raymond James Financial Services Advisors's Merck position peaked at $472M in Q1 2024.
  • 3,490 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.